AU4454389A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
AU4454389A
AU4454389A AU44543/89A AU4454389A AU4454389A AU 4454389 A AU4454389 A AU 4454389A AU 44543/89 A AU44543/89 A AU 44543/89A AU 4454389 A AU4454389 A AU 4454389A AU 4454389 A AU4454389 A AU 4454389A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44543/89A
Inventor
Hans Peter Bier
Wolfgang Czarnecki
Jean Claude Gfeller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU4454389A publication Critical patent/AU4454389A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
AU44543/89A 1984-06-14 1989-11-09 Pharmaceutical composition Abandoned AU4454389A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3422083 1984-06-14
DE3442566 1984-11-22
DE3442566 1984-11-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU43486/85A Division AU587190B2 (en) 1984-06-14 1985-06-12 Novel galenical retard form

Publications (1)

Publication Number Publication Date
AU4454389A true AU4454389A (en) 1990-03-22

Family

ID=25822108

Family Applications (2)

Application Number Title Priority Date Filing Date
AU43486/85A Ceased AU587190B2 (en) 1984-06-14 1985-06-12 Novel galenical retard form
AU44543/89A Abandoned AU4454389A (en) 1984-06-14 1989-11-09 Pharmaceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU43486/85A Ceased AU587190B2 (en) 1984-06-14 1985-06-12 Novel galenical retard form

Country Status (21)

Country Link
AT (1) AT391806B (en)
AU (2) AU587190B2 (en)
BE (1) BE902626A (en)
CA (1) CA1264441A (en)
CY (1) CY1635A (en)
DE (1) DE3520184C2 (en)
DK (1) DK167649B1 (en)
ES (1) ES8702141A1 (en)
FR (1) FR2565822B1 (en)
GB (3) GB2160100B (en)
GR (1) GR851430B (en)
HK (1) HK25192A (en)
HU (1) HU198844B (en)
IE (1) IE58834B1 (en)
IL (1) IL75490A0 (en)
IT (1) IT1200080B (en)
LU (1) LU85946A1 (en)
NL (1) NL194389C (en)
NZ (1) NZ212390A (en)
PT (1) PT80635B (en)
SE (1) SE504583C2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (en) * 1985-10-15 1987-12-23 Eurand Spa PROCEDURE FOR THE PREPARATION OF SOLID FORMULATIONS OF NIFEDIPINE WITH HIGH BIO AVAILABILITY AND WITH PROLONGED EFFECT AND FORMULATIONS SO OBTAINED
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec PHARMACEUTICAL PREPARATION
MX9300110A (en) * 1992-01-13 1994-07-29 Gerhard Gergely PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
DE4201179A1 (en) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
JP3148256B2 (en) 1996-07-08 2001-03-19 エドワード メンデル カンパニー．，インコーポレーテッド Sustained release matrix for high dose poorly soluble drugs
DE19710009A1 (en) * 1997-03-12 1998-09-24 Knoll Ag Multi-phase preparation forms containing active ingredients
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
AU5483600A (en) * 1999-06-11 2001-01-02 Jean A. Chmielewski Pharmaceutical materials and methods for their preparation and use
PT1205190E (en) * 1999-08-04 2006-09-29 Astellas Pharma Inc MEDICINAL COMPOSITIONS STABLE FOR ORAL USE USING IRON OXIDES
DE60038536T2 (en) 1999-09-30 2009-06-10 Penwest Pharmaceuticals Co. MATRIX SYSTEM WITH DELAYED RELEASE FOR HIGHLY SOLUBLE ACTIVE SUBSTANCES
EP1368006B1 (en) * 2001-02-13 2006-05-03 AstraZeneca AB Novel modified released formulation
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (en) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
WO2008070118A1 (en) 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
CA2734646C (en) 2008-08-20 2016-06-28 James W. Mcginity Hot-melt extrusion of modified release multi-particulates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (en) * 1967-11-17 1971-03-25 Beiersdorf Ag Process for the production of medicaments with delayed release of active substances in the form of capsules
DE2400819C2 (en) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Process for the production of solid preparations of poorly soluble active pharmaceutical ingredients in extremely fine distribution
DE2546577B2 (en) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Solid substances made from polyvinylpyrrolidone and ergot alkaloids
GB1504553A (en) * 1975-11-17 1978-03-22 Sandoz Ltd Tablet formulations
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
DK149855C (en) * 1977-06-20 1987-04-21 Sandoz Ag METHOD OF ANALOGY FOR THE PREPARATION OF 1,4-DIHYDROPYRIDINE DERIVATIVES
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
WO1980001242A1 (en) * 1978-12-21 1980-06-26 Sandoz Ag Galenical preparation
DE2904310A1 (en) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (en) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
EP0078430B2 (en) * 1981-10-29 1993-02-10 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (en) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen TWO-PHASE FORMULATION

Also Published As

Publication number Publication date
GB2160100B (en) 1989-06-01
NZ212390A (en) 1992-02-25
GB2196852A (en) 1988-05-11
ES544075A0 (en) 1987-01-01
GB2196851B (en) 1989-06-07
AU4348685A (en) 1985-12-19
LU85946A1 (en) 1986-01-24
DK264785D0 (en) 1985-06-12
CA1264441A (en) 1990-01-16
GB2196852B (en) 1989-05-17
IT8548210A0 (en) 1985-06-13
GB2196851A (en) 1988-05-11
GB8514855D0 (en) 1985-07-17
SE504583C2 (en) 1997-03-10
CY1635A (en) 1992-11-06
IT1200080B (en) 1989-01-05
NL194389B (en) 2001-11-01
IE851460L (en) 1985-12-14
ES8702141A1 (en) 1987-01-01
NL194389C (en) 2002-03-04
GB8727056D0 (en) 1987-12-23
HK25192A (en) 1992-04-10
FR2565822B1 (en) 1989-02-17
NL8501578A (en) 1986-01-02
FR2565822A1 (en) 1985-12-20
IL75490A0 (en) 1985-10-31
GB2160100A (en) 1985-12-18
HU198844B (en) 1989-12-28
GR851430B (en) 1985-11-25
SE8502950D0 (en) 1985-06-13
DK264785A (en) 1985-12-15
AU587190B2 (en) 1989-08-10
PT80635A (en) 1985-07-01
DE3520184C2 (en) 1997-03-13
HUT40918A (en) 1987-03-30
PT80635B (en) 1987-10-20
IE58834B1 (en) 1993-11-17
AT391806B (en) 1990-12-10
ATA174885A (en) 1990-06-15
GB8727055D0 (en) 1987-12-23
BE902626A (en) 1985-12-10
DE3520184A1 (en) 1985-12-19
SE8502950L (en) 1985-12-15
DK167649B1 (en) 1993-12-06

Similar Documents

Publication Publication Date Title
GB2153678B (en) Pharmaceutical composition
AU580117B2 (en) Analgesic compositions
AU591161B2 (en) Fly-attractive composition
EP0173990A3 (en) External pharmaceutical composition
AU4454389A (en) Pharmaceutical composition
ZA853823B (en) Pharmaceutical composition
GB2165451B (en) Pharmaceutical compositions
GB8410290D0 (en) Pharmaceutical compositions
GB8410289D0 (en) Pharmaceutical compositions
GB2153677B (en) Pharmaceutical composition
GB8513641D0 (en) Pharmaceutical composition
GB8409961D0 (en) Pharmaceutical compositions
AU584547B2 (en) Pharmaceutical `` -aminoalkyl- `` -alkylphenylacetonitriles
AU587505B2 (en) Pharmaceutical compositions
GB2153676B (en) Pharmaceutical composition
GB8518565D0 (en) Pharmaceutical composition
AU578657B2 (en) Pharmaceutical compositions
AU7819887A (en) Pharmaceutical composition
GB8412995D0 (en) Pharmaceutical composition
GB8421779D0 (en) Pharmaceutical composition
GB8424514D0 (en) Pharmaceutical composition
GB8424512D0 (en) Pharmaceutical composition
GB8426767D0 (en) Pharmaceutical composition
GB8429710D0 (en) Pharmaceutical composition
GB8421583D0 (en) Pharmaceutical composition